Jha Priyanka, Bijan Bijan
Department of Radiology and Nuclear Medicine, University of California Davis Medical Center, Sacramento, California.
Department of Radiology and Nuclear Medicine, University of California Davis Medical Center, Sacramento, California
J Nucl Med Technol. 2015 Jun;43(2):92-7. doi: 10.2967/jnmt.114.145458. Epub 2015 Apr 9.
Pancreatic malignancy carries a poor prognosis and is the fourth leading cause of cancer-related deaths in the United States. Although conventional imaging with CT and MR remains the main imaging modality, recent times have seen an increase in the applications of PET/CT in the evaluation of pancreatic malignancy. Newer data are becoming available, highlighting the advantages, limitations, and pitfalls in PET/CT imaging of the pancreas. This article highlights the applications of PET/CT in various stages of management of pancreatic malignancy and compares these with conventional imaging with CT and MR.
胰腺恶性肿瘤预后较差，是美国癌症相关死亡的第四大主要原因。尽管传统的CT和MR成像仍是主要的成像方式，但近年来PET/CT在胰腺恶性肿瘤评估中的应用有所增加。更新的数据不断涌现，凸显了PET/CT胰腺成像的优势、局限性和陷阱。本文重点介绍PET/CT在胰腺恶性肿瘤不同管理阶段的应用，并将其与传统的CT和MR成像进行比较。
